How To Get A Meeting With FDA: Guidance Describes Formal Meetings For Biosimilars
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA’s fourth biosimilars-related guidance describes the formal meeting process for sponsors with products in development; the process will require extensive requests and information packages.